Some of it is a long way off, but that's why this has been and continues to be a long-term hold. People who whine and complain about the day to day short-term are missing the point. All of the short-term potential is designed to support the potential of MANF and that's why I have no problem with them taking their time now to get things right.
I don't think I'm telling anybody anything they don't already know, but I think people get so caught up in Lympro and the daily pps that they forget about the potential value of MANF. News of more indications should refocus people, but I'm sure it won't.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links